The new FIGO 2023 staging reclassification of patients with FIGO 2009 Stage IVB endometrial cancer correlates to progression-free and overall survival outcomes
The clinical outcomes of patients with Stage IVB are varied depending mainly on the disease distribution. Patients with abdominal or pelvic disease had better survival outcomes and therefore, needed a different categorisation. Thus, FIGO 2023 Staging considers this varied disease distribution and appears to be a better prognostic indicator for this group.
Authors
- W.M. Jose (ORCID: https://orcid.org/0000-0002-5494-7158)
- K Pavithran (ORCID: https://orcid.org/0000-0002-6129-5709)
- Priya Bhati (ORCID: https://orcid.org/0000-0002-0886-9611)
- V S Sheejamol (ORCID: https://orcid.org/0000-0002-4184-1119)
- Pranidha Shree CA
- Monal Garg
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1016/j.gore.2024.101527
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00